This study shows that catalase activity is reduced in patients with decreased myeloid lineage cell; however, patients with leukocytosis from chronic myeloid leukemia had high catalase activity [36]. Here, CAT is linked to chronic myelogenous leukemia, BCR-ABL1 positive.